Middle East & Africa Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy And Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
The Middle East and Africa Point of Care (POC) Diagnostics Market is projected to grow significantly, reaching an estimated US$ 3,524.0 million by 2031, up from US$ 1,670.9 million in 2024. This growth represents a compound annual growth rate (CAGR) of 11.3% from 2025 to 2031.
Executive Summary and Market Analysis
The POC diagnostics market in the region is divided into key areas including South Africa, Saudi Arabia, the UAE, and the broader Middle East and Africa. The anticipated growth in this sector is primarily driven by the rising prevalence of chronic and infectious diseases such as diabetes, cancer, HIV, and cardiovascular disorders, which create a heightened demand for rapid and precise diagnostic tools.
Governments in the region are actively promoting healthcare advancements through increased funding, public health initiatives, and the integration of cutting-edge diagnostic technologies. Additionally, there is a growing investment in healthcare infrastructure aimed at improving access to medical services, particularly in rural and underserved communities. The rising awareness regarding the importance of early disease detection and the adoption of innovative, portable diagnostic devices are also contributing to the increased uptake of POC testing, thereby enhancing the market outlook in the Middle East and Africa.
Strategic Insights
The Middle East and Africa POC Diagnostics Market is categorized by various segments:
The integration of artificial intelligence (AI) and machine learning (ML) into diagnostic devices is revolutionizing healthcare by facilitating faster, more accurate, and personalized diagnostics outside traditional clinical environments. AI-enhanced POC devices are improving diagnostic capabilities, aiding decision-making, and minimizing human error. For instance, companies like Abbott Laboratories have developed AI-driven POC devices for continuous glucose monitoring, such as the Freestyle Libre system, which utilizes machine learning to provide personalized insights based on glucose trends, assisting diabetes management.
Moreover, AI is being incorporated into rapid COVID-19 testing kits, significantly reducing testing times and enabling quicker results at the point of care, thus improving the management of infectious disease outbreaks. The growing partnerships among market players to develop AI-based POC diagnostics are expected to further boost their adoption.
In April 2025, Unilabs Middle East introduced the Hologic Genius™ Digital Diagnostics System in the UAE, marking the region's first AI-powered digital cytology technology. This system employs deep learning-based AI and advanced imaging techniques to enhance the speed and accuracy of cervical cancer diagnoses, aligning with national health objectives to reduce cervical cancer rates and improve early detection.
Country Insights
The market is also analyzed by country, with South Africa holding the largest share in 2024. The country faces a rising cancer prevalence, with the WHO reporting over 111,000 new cases and nearly 65,000 cancer-related deaths annually. Additionally, the increasing incidence of diabetes, driven by urbanization and lifestyle changes, is notable, with approximately 4.2 million people living with diabetes in South Africa as of 2021.
Government initiatives, such as the National Health Insurance (NHI), are facilitating access to free healthcare services at the point of care in both public and accredited private facilities, further supporting the growth of the POC diagnostics market in South Africa.
Key Players
Prominent companies in the Middle East and Africa POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.
Executive Summary and Market Analysis
The POC diagnostics market in the region is divided into key areas including South Africa, Saudi Arabia, the UAE, and the broader Middle East and Africa. The anticipated growth in this sector is primarily driven by the rising prevalence of chronic and infectious diseases such as diabetes, cancer, HIV, and cardiovascular disorders, which create a heightened demand for rapid and precise diagnostic tools.
Governments in the region are actively promoting healthcare advancements through increased funding, public health initiatives, and the integration of cutting-edge diagnostic technologies. Additionally, there is a growing investment in healthcare infrastructure aimed at improving access to medical services, particularly in rural and underserved communities. The rising awareness regarding the importance of early disease detection and the adoption of innovative, portable diagnostic devices are also contributing to the increased uptake of POC testing, thereby enhancing the market outlook in the Middle East and Africa.
Strategic Insights
The Middle East and Africa POC Diagnostics Market is categorized by various segments:
- By Product: The market includes categories such as Glucose Monitoring, Infectious Disease Testing, Cardio Metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and others. In 2024, Glucose Monitoring held the largest market share.
- By Glucose Monitoring: This segment is further divided into Blood Glucose Meters, Lancets, and Strips, with Strips leading the market share in 2024.
- By Infectious Disease Testing: This includes HIV Testing, Influenza Testing, and others, with Respiratory Infection Testing being the largest segment in 2024.
- By Cardio Metabolic Testing: This includes tests like Cardiac Troponin (cTn) Test, which also held the largest share in 2024.
- By Purchase Mode: The market is segmented into Over-the-Counter (OTC) and Prescription, with Prescription holding the majority share.
- By Sample Type: Blood samples dominated the market in 2024.
- By End User: Healthcare Facilities, particularly Diagnostic Centers, accounted for the largest share in 2024.
The integration of artificial intelligence (AI) and machine learning (ML) into diagnostic devices is revolutionizing healthcare by facilitating faster, more accurate, and personalized diagnostics outside traditional clinical environments. AI-enhanced POC devices are improving diagnostic capabilities, aiding decision-making, and minimizing human error. For instance, companies like Abbott Laboratories have developed AI-driven POC devices for continuous glucose monitoring, such as the Freestyle Libre system, which utilizes machine learning to provide personalized insights based on glucose trends, assisting diabetes management.
Moreover, AI is being incorporated into rapid COVID-19 testing kits, significantly reducing testing times and enabling quicker results at the point of care, thus improving the management of infectious disease outbreaks. The growing partnerships among market players to develop AI-based POC diagnostics are expected to further boost their adoption.
In April 2025, Unilabs Middle East introduced the Hologic Genius™ Digital Diagnostics System in the UAE, marking the region's first AI-powered digital cytology technology. This system employs deep learning-based AI and advanced imaging techniques to enhance the speed and accuracy of cervical cancer diagnoses, aligning with national health objectives to reduce cervical cancer rates and improve early detection.
Country Insights
The market is also analyzed by country, with South Africa holding the largest share in 2024. The country faces a rising cancer prevalence, with the WHO reporting over 111,000 new cases and nearly 65,000 cancer-related deaths annually. Additionally, the increasing incidence of diabetes, driven by urbanization and lifestyle changes, is notable, with approximately 4.2 million people living with diabetes in South Africa as of 2021.
Government initiatives, such as the National Health Insurance (NHI), are facilitating access to free healthcare services at the point of care in both public and accredited private facilities, further supporting the growth of the POC diagnostics market in South Africa.
Key Players
Prominent companies in the Middle East and Africa POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Point of Care Diagnostics Market Forecast and Analysis
7. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy and Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 Middle East & Africa
15.1.1 Middle East & Africa Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Middle East & Africa Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
15.4.5.5 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.4.5.5.6 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.4.5.5.7 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.4.5.5.8 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Point of Care Diagnostics Market Forecast and Analysis
7. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy and Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. MIDDLE EAST & AFRICA POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 Middle East & Africa
15.1.1 Middle East & Africa Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Middle East & Africa Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 South Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
15.4.5.5 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Product
15.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Glucose Monitoring
15.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Purchase Mode
15.4.5.5.6 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Sample
15.4.5.5.7 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by End User
15.4.5.5.8 Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa Point of Care Diagnostics Market Segmentation
Table 3. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 37. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 38. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 39. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 40. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 41. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 42. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 43. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 44. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 1. Middle East & Africa Point of Care Diagnostics Market Segmentation
Table 3. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 37. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 38. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 39. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 40. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 41. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 42. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 43. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 44. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
LIST OF FIGURES
Figure 1. Middle East & Africa Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. Middle East & Africa Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Middle East & Africa Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 55. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Middle East & Africa Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. Middle East & Africa Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Middle East & Africa Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Middle East & Africa Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. South Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Saudi Arabia: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. United Arab Emirates: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 55. Rest of Middle East & Africa: Middle East & Africa Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
